The Latest Breaking News from FDA

WASHINGTON – Sen. John Cornyn earned a spot on Donald Trump’s naughty list by saying the GOP should pick someone else for president in 2024.

It is only the seventh case of the deadly disease reported in the U.S. since it first emerged in the country in 2003.

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on….

Karl Warburton, 43, died last May from xylazine, which is used by vets as a tranquilliser for large animals such as horses and cows - the drug has never been approved for human use as it can cause flesh-rotting sores on takers’ skin

Xylazine is a powerful sedative which has swept across the United States.

A British man has become the first confirmed to have died after taking powerful drug Xylazine, dubbed the zombie drug, in the UK after dozens across the United States

A House panel advanced a 2024 budget bill that would block the ability to access the abortion drug via telehealth

This CEO is going to against the better judgment of the FDA to remain youthful.

Drug shortages in the US are forcing physicians and the public to scramble for access to vital medicines. While the problem isn’t new, the number of products in scarce supply is nearing an all-time high — and could get worse as generic drug makers pare back on the breadth of…

Opvee is similar to naloxone, the life-saving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl and prescription painkillers.

U.S. health regulators have approved a new nasal spray to reverse overdoses due to fentanyl and other powerful opioids